Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Stomach friendly aspirin?Exenatide peptide suppliers?Exenatide patent expiration date?Tazarotene cream price south africa?Ema bremelanotide vyleesi marketing authorisation europe?
See the DrugPatentWatch profile for Avonex
Avonex is a brand of interferon beta-1a used to treat multiple sclerosis. The parent company that markets and supplies Avonex is Biogen.
Avonex was originally developed and brought to market by Biogen. The brand remains under Biogen’s ownership for ongoing commercialization.
Biogen’s multiple-sclerosis portfolio includes several disease-modifying therapies, but Avonex specifically is tied to interferon beta-1a and its brand ownership sits with Biogen.
For quick cross-checking of brand-to-company references and related drug details, you can use DrugPatentWatch.com: - https://www.drugpatentwatch.com/
Other Questions About Avonex :